Eplerenone Tablet, Coated
Product Images NDC 71205-864

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 71205-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Eplerenone 01)

Chemical structure of eplerenone, showing its steroidal core with various functional groups, including carbonyl and ester groups, arranged in a complex three-dimensional conformation.*

FDA Label Image

Figure 1 (Eplerenone 02)

A survival curve chart showing cumulative incidence (%) over 27 months since randomization comparing Placebo and Eplerenone groups. The plot indicates lower cumulative incidence in the Eplerenone group relative to Placebo, with statistical values including p = 0.008 and relative risk (RR) = 0.85 (95% CI, 0.75-0.96). The chart also presents the number of subjects at risk at various time points for both groups.*

FDA Label Image

Figure 2 (Eplerenone 03)

A forest plot figure titled 'Hazard Ratios of All-Cause Mortality by Subgroups' displaying hazard ratios with confidence intervals for various patient subgroups such as age, gender, race, diabetes status, hypertension status, Killip class, creatinine clearance, and baseline medication use. Each subgroup is listed with corresponding total number of events and patients, with a horizontal axis showing hazard ratios where values less than 1 favor Eplerenone and values greater than 1 favor placebo.*

FDA Label Image

Figure 3 (Eplerenone 04)

A scatter plot chart showing reduction in systolic blood pressure (SBP) in mm Hg on the vertical axis versus daily dose of Eplerenone in mg on the horizontal axis. The plot includes data points from three studies identified as Study 1 QD, Study 2 QD, and Study 2 BID, represented by different symbols.*

FDA Label Image

Figure 4 (Eplerenone 05)

A scatter plot chart showing the reduction in diastolic blood pressure (DBP) in millimeters of mercury (mm Hg) as a function of daily doses of Eplerenone in mg/day from two separate studies. Different markers represent Study 1 once daily (QD), Study 2 once daily (QD), and Study 2 twice daily (BID) dosing regimens.*

FDA Label Image

71205-863-30 (Eplerenone 06)

Label for Eplerenone 25 mg coated tablets from Proficient Rx LP. The package contains 30 round, beige, biconvex film-coated tablets, each containing 25 mg of eplerenone. Tablets are debossed with "25" on one side. Manufactured by Bluepharma Indústria Farmacêutica in Portugal.*

FDA Label Image

71205-864-30 (Eplerenone 07)

Label for Eplerenone 50 mg coated tablets by Proficient Rx LP. The package contains 30 beige, round, biconvex tablets debossed with "50" on one side. The label displays manufacturer information as Bluepharma Indústria Farmacêutica, S.A. and storage instructions at 25°C (77°F). The label includes the NDC 71205-864-30 and states RX only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.